References
1. Home - Johns Hopkins Coronavirus Resource Center [Internet].
[cited 2021 Feb 6]. Available from: https://coronavirus.jhu.edu/
2. Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P, Dehmer GJ, et
al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use
Criteria for Multimodality Imaging in the Assessment of Cardiac
Structure and Function in Nonvalvular Heart Disease: A Report of the
American College of Cardiology Appropriate Use Criteria. J Am Soc
Echocardiogr Off Publ Am Soc Echocardiogr. United States;
2019;32:553–79.
3. Dandel M. AO - Dandel MO http://orcid. org/000.-0002-7131-9057.
Cardiac manifestations of COVID-19 infection: the role of
echocardiography in patient management. Infection. M. Dandel, German
Centre for Heart and Circulatory Research (DZHK) Partner Site Berlin,
Berlin, Germany. E-mail: mdandel@aol.com: Springer; 2020;
4. Gupta A, Madhavan M V., Sehgal K, Nair N, Mahajan S, Sehrawat TS, et
al. Extrapulmonary manifestations of COVID-19. Nat. Med. Nature
Research; 2020. p. 1017–32.
5. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and
Myocardial Infarction. N Engl J Med. United States; 2019;380:171–6.
6. Singh N, Anchan RK, Besser SA, Belkin MN, Cruz MD, Lee L, et al. High
sensitivity Troponin-T for prediction of adverse events in patients with
COVID-19. Biomarkers. Taylor and Francis Ltd.; 2020;25:626–33.
7. Majure DT, Gruberg L, Saba SG, Kvasnovsky C, Hirsch JS, Jauhar R.
Usefulness of Elevated Troponin to Predict Death in Patients With
COVID-19 and Myocardial Injury. Am J Cardiol. Elsevier Inc.;
2021;138:100–6.
8. Zhao BC, Liu WF, Lei SH, Zhou BW, Yang X, Huang TY, et al. Prevalence
and prognostic value of elevated troponins in patients hospitalised for
coronavirus disease 2019: a systematic review and meta-analysis. J
Intensive Care. BioMed Central Ltd; 2020;8.
9. Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick
JI, et al. Coronavirus and Cardiovascular Disease, Myocardial Injury,
and Arrhythmia: JACC Focus Seminar. J. Am. Coll. Cardiol. Elsevier Inc.;
2020. p. 2011–23.
10. Malik P, Patel U, Patel NH, Somi S, Singh J. Elevated cardiac
troponin i as a predictor of outcomes in covid-19 hospitalizations: A
meta-analysis. Infez. Med. 2020. p. 500–6.
11. Pranata R, Huang I, Lukito AA, Raharjo SB. Elevated N-terminal
pro-brain natriuretic peptide is associated with increased mortality in
patients with COVID-19: systematic review and meta-analysis. Postgrad
Med J. 2020;96:387 LP – 391.
12. Jain SS, Liu Q, Raikhelkar J, Fried J, Elias P, Poterucha TJ, et al.
Indications for and Findings on Transthoracic Echocardiography in
COVID-19. J Am Soc Echocardiogr. Mosby Inc.; 2020;33:1278–84.
13. Nguyen LH, Drew DA, Joshi AD, Guo C-G, Ma W, Mehta RS, et al. Risk
of COVID-19 among frontline healthcare workers and the general
community: a prospective cohort study. medRxiv Prepr Serv Heal Sci. Cold
Spring Harbor Laboratory; 2020;2020.04.29.20084111.
14. Garg VP, Isath A, Argulian E, Lerakis S, Narula J. Impact of
COVID-19 Pandemic on the Role of Cardiac Sonographers. J Am Soc
Echocardiogr. Mosby-Year Book; 2020;S0894-7317(20)30711-2.
15. J.N. K, C. M, C. T, S. K, J. H, Kirkpatrick JN, et al. ASE Statement
on Protection of Patients and Echocardiography Service Providers During
the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of
Cardiology. J Am Coll Cardiol. M. Swaminathan, Duke University Medical
Center, Anesthesiology, Box 3094, DUMC Box 3094, Durham, NC 27710,
United States. E-mail: madhav.swaminathan@duke.edu: Elsevier USA;
2020;33:648–53.
16. Creel-Bulos C, Hockstein M, Amin N, Melhem S, Truong A, Sharifpour
M. Acute Cor Pulmonale in Critically Ill Patients with Covid-19. N Engl
J Med. Massachusetts Medical Society; 2020;382:e70.
17. Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et
al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic
Echocardiographic Study. Circulation. Y. Topilsky, Department of
Cardiology, Tel Aviv Medical Center, Weizmann 6, Tel Aviv 6423919,
Israel. E-mail: topilskyyan@gmail.com: Lippincott Williams and Wilkins
(E-mail: kathiest.clai@apta.org); 2020;342–53.
18. E. G-C, D. M-S, R. R-S, R. G-N, R.L. B-C, A. J-R, et al. Critical
care ultrasonography during COVID-19 pandemic: The ORACLE protocol.
Echocardiography. D. Manzur-Sandoval, Cardiovascular Critical Care Unit,
Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
E-mail: drdanielmanzur@gmail.com: Blackwell Publishing Inc. (E-mail:
subscrip@blackwellpub.com); 2020;
19. Bursi F, Santangelo G, Sansalone D, Valli F, Vella AM, Toriello F,
et al. Prognostic utility of quantitative offline 2D-echocardiography in
hospitalized patients with COVID-19 disease. Echocardiography. 2020;
20. Mahmoud-Elsayed HM, Moody WE, Bradlow WM, Khan-Kheil AM, Senior J,
Hudsmith LE, et al. Echocardiographic Findings in Patients With COVID-19
Pneumonia. Can J Cardiol. Elsevier Inc.; 2020;36:1203–7.
21. Schott JP, Mertens AN, Bloomingdale R, O’Connell TF, Gallagher MJ,
Dixon S, et al. Transthoracic echocardiographic findings in patients
admitted with SARS-CoV-2 infection. Echocardiography. Pharmacotherapy
Publications Inc.; 2020;
22. Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19
pneumonia: the clot thickens! Eur. Respir. J. 2020.
23. Nuche J, Segura de la Cal T, Jiménez López Guarch C, López-Medrano
F, Delgado CP-O, Ynsaurriaga FA, et al. Effect of Coronavirus Disease
2019 in Pulmonary Circulation. The Particular Scenario of Precapillary
Pulmonary Hypertension. Diagnostics (Basel, Switzerland). MDPI;
2020;10:548.
24. van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J,
de Jonge E, et al. Clinical and computed tomography characteristics of
COVID-19 associated acute pulmonary embolism: A different phenotype of
thrombotic disease? Thromb Res. 2020;193:86–9.
25. Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al.
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection
(COVID-19)? Eur Respir J. European Respiratory Society; 2020;56:2001634.
26. Yun-Long Li Yu Jin, Rong Tang, Ming Li, Chun-Hong Xiu, Qing-Qing
Dai, Shu Zuo, Huai-Quan Wang, Hong-Liang Wang, Ming-Yan Zhao, Ming Ye,
Kai-Jiang Yu J-BZ. Acute right ventricular dysfunction in severe
COVID-19 pneumonia. Rev. Cardiovasc. Med. p. 635–41.
27. D’Alto M, Marra AM, Severino S, Salzano A, Romeo E, De Rosa R, et
al. Right ventricular-arterial uncoupling independently predicts
survival in COVID-19 ARDS. Crit Care. 2020;24:670.
28. Churchill TW, Bertrand PB, Bernard S, Namasivayam M, Churchill J,
Crousillat D, et al. Echocardiographic Features of COVID-19 Illness and
Association with Cardiac Biomarkers. J Am Soc Echocardiogr. United
States: Mosby Inc. (E-mail: customerservice@mosby.com); 2020;33:1053–4.
29. Sud K, Vogel B, Bohra C, Garg V, Talebi S, Lerakis S, et al.
Echocardiographic Findings in Patients with COVID-19 with Significant
Myocardial Injury. J. Am. Soc. Echocardiogr. Mosby Inc.; 2020. p.
1054–5.
30. Stöbe S, Richter S, Seige M, Stehr S, Laufs U, Hagendorff A, et al.
Echocardiographic characteristics of patients with SARS-CoV-2 infection.
Clin Res Cardiol. S. Stobe, Department of Cardiology, Leipzig University
Hospital, Liebigstr. 20, Leipzig 04103, Germany. E-mail:
stephan.stoebe@gmx.de: Springer; 2020;
31. Esposito R, Santoro C, Sorrentino R, Riccio E, Citro R, Buonauro A,
et al. Layer-specific longitudinal strain in Anderson-Fabry disease at
diagnosis: A speckle tracking echocardiography analysis.
Echocardiography. United States; 2019;36:1273–81.
32. Weidemann F, Niemann M, Ertl G, Störk S. The different faces of
echocardiographic left ventricular hypertrophy: clues to the etiology. J
Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. United States;
2010;23:793–801.
33. Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi
M, et al. Characterization of Myocardial Injury in Patients With
COVID-19. J Am Coll Cardiol. by the American College of Cardiology
Foundation. Published by Elsevier.; 2020;76:2043–55.
34. Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B.
Thromboembolism risk of COVID-19 is high and associated with a higher
risk of mortality: A systematic review and meta-analysis.
EClinicalMedicine. 2020;29:100639.
35. Beşler MS, Arslan H. Acute myocarditis associated with COVID-19
infection. Am J Emerg Med. 2020/06/02. Elsevier Inc.;
2020;38:2489.e1-2489.e2.
36. Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno
C, et al. Systematic review of COVID-19 related myocarditis: Insights on
management and outcome. Cardiovasc Revasc Med. Elsevier Inc.;
2020;S1553-8389(20)30497-8.
37. Amoozgar B, Kaushal V, Mubashar U, Sen S, Yousaf S, Yotsuya M, et
al. Symptomatic pericardial effusion in the setting of asymptomatic
COVID-19 infection: A case report. Medicine (Baltimore). United States:
NLM (Medline); 2020;99:e22093.
38. Ejikeme C, Gonzalez M, Elkattawy S, Alyacoub R, Sherer C. Subacute
COVID-19 Infection Presenting as Indolent Large Pericardial Effusion.
Cureus. Cureus; 2020;12:e10769–e10769.
39. Fox K, Prokup JA, Butson K, Jordan K. Acute Effusive Pericarditis: A
Late Complication of COVID-19. Cureus. Cureus; 2020;12:e9074–e9074.
40. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et
al. Cardiac Involvement in a Patient with Coronavirus Disease 2019
(COVID-19). JAMA Cardiol. American Medical Association; 2020;5:819–24.
41. Asif T, Kassab K, Iskander F, Alyousef T. Acute Pericarditis and
Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.
Eur J case reports Intern Med. SMC Media Srl; 2020;7:1701.
42. Purohit R, Kanwal A, Pandit A, Patel BM, Meininger GR, Brown JJ, et
al. Acute myopericarditis with pericardial effusion and cardiac
tamponade in a patient with COVID-19. Am J Case Rep. International
Scientific Information, Inc.; 2020;21:1–4.
43. Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB.
Cardiac Tamponade Secondary to COVID-19. JACC Case reports. 2020/04/23.
The Authors. Published by Elsevier on behalf of the American College of
Cardiology Foundation.; 2020;2:1326–30.
44. Goudot G, Chocron R, Augy J-L, Gendron N, Khider L, Debuc B, et al.
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity
Troponin and D-Dimer and Correlation With Right Ventricular Afterload.
Front Med. Frontiers Media S.A.; 2020;7:586307.
45. Li Y, Li H, Zhu S, Xie Y, Wang B, He L, et al. Prognostic Value of
Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC
Cardiovasc Imaging. 2020;
46. Liu Y, Xie J, Gao P, Tian R, Qian H, Guo F, et al. Swollen heart in
COVID-19 patients who progress to critical illness: a perspective from
echo-cardiologists. ESC Hear Fail. Wiley-Blackwell; 2020;
47. Krishnamoorthy P, Croft LB, Ro R, Anastasius M, Zhao W, Giustino G,
et al. Biventricular strain by speckle tracking echocardiography in
COVID-19: findings and possible prognostic implications. Future Cardiol.
Future Medicine Ltd; 2020;
48. Stockenhuber A, Vrettos A, Androschuck V, George M, Robertson C,
Bowers N, et al. A pilot study on right ventricular longitudinal strain
as a predictor of outcome in COVID-19 patients with evidence of cardiac
involvement. Echocardiography. John Wiley & Sons, Ltd; 2020;n/a.
49. García-Cruz E, Manzur-Sandoval D, Gopar-Nieto R, Murillo-Ochoa AL,
Bejarano-Alva G, Rojas-Velasco G, et al. Transthoracic echocardiography
during prone position ventilation: Lessons from the COVID-19 pandemic. J
Am Coll Emerg Physicians open. Wiley; 2020;
50. Giustiniano E, Padua E, Negri K, Bragato RM, Cecconi M, E. G, et al.
Echocardiography during Prone-Position Mechanical Ventilation in
Patients with COVID-19: A Proposal for a New Approach. J Am Soc
Echocardiogr. United States: Mosby Inc. (E-mail:
customerservice@mosby.com); 2020;33:905–6.
51. Muskula PR, Main ML. Safety With Echocardiographic Contrast Agents.
Circ Cardiovasc Imaging. United States; 2017;10.
52. Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF, et
al. Impact of contrast echocardiography on evaluation of ventricular
function and clinical management in a large prospective cohort. J Am
Coll Cardiol. United States; 2009;53:802–10.
53. E. A, K. S, C. B, B. V, V. G, S. T, et al. Safety of Ultrasonic
Enhancing Agents in Patients with COVID-19. J Am Soc Echocardiogr.
United States: Mosby Inc. (E-mail: customerservice@mosby.com);
2020;33:906–8.
54. Bleakley C, Smith R, Garfield B, Jackson T, Remmington C, Patel B
V., et al. Contrast Echocardiography in VV-ECMO-Dependent Patients with
COVID-19. J. Am. Soc. Echocardiogr. Mosby Inc.; 2020.
55. Vignon P, Merz TM, Vieillard-Baron A. Ten reasons for performing
hemodynamic monitoring using transesophageal echocardiography. Intensive
Care Med. 2017;43:1048–51.
56. Lhéritier G, Legras A, Caille A, Lherm T, Mathonnet A, Frat J-P, et
al. Prevalence and prognostic value of acute cor pulmonale and patent
foramen ovale in ventilated patients with early acute respiratory
distress syndrome: a multicenter study. Intensive Care Med. United
States; 2013;39:1734–42.
57. Vignon P, Repessé X, Bégot E, Léger J, Jacob C, Bouferrache K, et
al. Comparison of Echocardiographic Indices Used to Predict Fluid
Responsiveness in Ventilated Patients. Am J Respir Crit Care Med. United
States; 2017;195:1022–32.
58. Charbonneau H, Riu B, Faron M, Mari A, Kurrek MM, Ruiz J, et al.
Predicting preload responsiveness using simultaneous recordings of
inferior and superior vena cavae diameters. Crit Care. BioMed Central;
2014;18:473.
59. Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G,
et al. Acute heart failure and cardiogenic shock: a multidisciplinary
practical guidance. Intensive Care Med. United States; 2016;42:147–63.
60. Aneman A, Vieillard-Baron A. Cardiac dysfunction in sepsis.
Intensive Care Med. United States; 2016;42:2073–6.
61. Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD.
Two-dimensional assessment of right ventricular function: an
echocardiographic-MRI correlative study. Echocardiography. United
States; 2007;24:452–6.
62. Li Y, Wang Y, Yang Y, Liu M, Meng X, Shi Y, et al. Tricuspid annular
displacement measured by 2-dimensional speckle tracking echocardiography
for predicting right ventricular function in pulmonary hypertension: A
new approach to evaluating right ventricle dysfunction. Medicine
(Baltimore). 2018;97:e11710.
63. Beyls C, Bohbot Y, Huette P, Abou-Arab O, Mahjoub Y, C. B, et al.
Tricuspid Longitudinal Annular Displacement for the Assessment of Right
Ventricular Systolic Dysfunction during Prone Positioning in Patients
with COVID-19. J Am Soc Echocardiogr. United States: Mosby Inc. (E-mail:
customerservice@mosby.com); 2020;33:1055–7.
64. Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E,
et al. Extracorporeal membrane oxygenation support in COVID-19: an
international cohort study of the Extracorporeal Life Support
Organization registry. Lancet (London, England). 2020;396:1071–8.
65. Alom S, Haiduc AA, Melamed N, Axiaq A, Harky A. Use of ECMO in
Patients With Coronavirus Disease 2019: Does the Evidence Suffice? J
Cardiothorac Vasc Anesth. Elsevier Inc.; 2020;S1053-0770(20)30743-6.
66. Douflé G, Roscoe A, Billia F, Fan E. Echocardiography for adult
patients supported with extracorporeal membrane oxygenation. Crit Care.
2015;19:326.
67. Platts DG, Sedgwick JF, Burstow DJ, Mullany DV, Fraser JF. The role
of echocardiography in the management of patients supported by
extracorporeal membrane oxygenation. J Am Soc Echocardiogr Off Publ Am
Soc Echocardiogr. United States; 2012;25:131–41.
68. Teran F, Burns KM, Narasimhan M, Goffi A, Mohabir P, Horowitz JM, et
al. Critical Care Transesophageal Echocardiography in Patients during
the COVID-19 Pandemic. J Am Soc Echocardiogr. Mosby Inc.;
2020;33:1040–7.
69. Griffee MJ, Zimmerman JM, McKellar SH, Tonna JE.
Echocardiography-Guided Dual-Lumen Venovenous Extracorporeal Membrane
Oxygenation Cannula Placement in the ICU-A Retrospective Review. J
Cardiothorac Vasc Anesth. 2020;34:698–705.
70. Cianchi G, Lazzeri C, Bonizzoli M, Batacchi S, Peris A. Echo-Guided
Insertion of a Dual-Lumen Cannula for Venovenous Extracorporeal Membrane
Oxygenation. ASAIO J. United States; 2019;65:414–6.
71. Banfi C, Pozzi M, Siegenthaler N, Brunner M-E, Tassaux D, Obadia
J-F, et al. Veno-venous extracorporeal membrane oxygenation: cannulation
techniques. J Thorac Dis. 2016;8:3762–73.
72. ICU ERT on E in. International consensus statement on training
standards for advanced critical care echocardiography. Intensive Care
Med. 2014;40:654–66.
73. Charron C, Vignon P, Prat G, Tonnelier A, Aegerter P, Boles J-M, et
al. Number of supervised studies required to reach competence in
advanced critical care transesophageal echocardiography. Intensive Care
Med. United States; 2013;39:1019–24.
74. Alharthy A, Faqihi F, Abuhamdah M, Noor A, Naseem N, Balhamar A, et
al. Prospective Longitudinal Evaluation of Point-of-Care Lung Ultrasound
in Critically Ill Patients With Severe COVID-19 Pneumonia. J Ultrasound
Med. John Wiley and Sons Ltd.; 2020;
75. Nouvenne A, Zani MD, Zani MD, Milanese G, Parise A, Baciarello M, et
al. Lung Ultrasound in COVID-19 Pneumonia: Correlations with Chest CT on
Hospital admission. Respiration. Switzerland: S. Karger AG; 2020;
76. Mafort TT, Lopes AJ, da Costa CH, da Cal MS, Lopes MC, da Silva BRA,
et al. Changes in lung ultrasound of symptomatic healthcare
professionals with COVID-19 pneumonia and their association with
clinical findings. J Clin Ultrasound. John Wiley and Sons Inc.; 2020;
77. Shumilov E, Hosseini ASA, Petzold G, Treiber H, Lotz J, Ellenrieder
V, et al. Comparison of Chest Ultrasound and Standard X-Ray Imaging in
COVID-19 Patients. Ultrasound Int Open. Georg Thieme Verlag KG;
2020;06:E36–40.
78. Lu W, Zhang S, Chen B, Chen J, Xian J, Lin Y, et al. A Clinical
Study of Noninvasive Assessment of Lung Lesions in Patients with
Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound. Ultraschall
Med. Germany; 2020;41:300–7.
79. Li S, Qu YL, Tu MQ, Guo LY, Zhang QL, Lv CY, et al. Application of
lung ultrasonography in critically ill patients with COVID-19.
Echocardiography. Blackwell Publishing Inc.; 2020;
80. J.R. P, I. C, K.C. M, M.M. L, J.N. D, K.P. N, et al. Point-of-care
lung ultrasound is more sensitive than chest radiograph for evaluation
of COVID-19. West J Emerg Med. United States: eScholarship (E-mail:
kfilipiak@aaem.org); 2020;21:771–8.
81. Calvo-Cebrián A, Alonso-Roca R, Rodriguez-Contreras FJ,
Rodríguez-Pascual M de las N, Calderín-Morales M del P. Usefulness of
Lung Ultrasound Examinations Performed by Primary Care Physicians in
Patients With Suspected COVID-19. J Ultrasound Med. John Wiley and Sons
Ltd.; 2020;
82. Fonsi GB, Sapienza P, Brachini G, Andreoli C, De Cicco ML, Cirillo
B, et al. Is Lung Ultrasound Imaging a Worthwhile Procedure for Severe
Acute Respiratory Syndrome Coronavirus 2 Pneumonia Detection? J
Ultrasound Med. John Wiley and Sons Ltd.; 2020;
83. Smargiassi A, Soldati G, Torri E, Mento F, Milardi D, Giacomo P Del,
et al. Lung Ultrasound for COVID-19 Patchy Pneumonia: Extended or
Limited Evaluations? J Ultrasound Med. John Wiley and Sons Ltd.; 2020;
84. Castelao J, Graziani D, Soriano JB, Izquierdo JL. Findings and
Prognostic Value of Lung Ultrasound in COVID-19 Pneumonia. J Ultrasound
Med. John Wiley and Sons Ltd.; 2020;
85. Gaspardone C, Meloni C, Preda A, Romagnolo D, Brugliera L,
Castellazzi P, et al. Lung Ultrasound in COVID-19 A Role Beyond the
Acute Phase? J Ultrasound Med. John Wiley and Sons Ltd.; 2020;
86. Lichter Y, Topilsky Y, Taieb P, Banai A, Hochstadt A, Merdler I, et
al. Lung ultrasound predicts clinical course and outcomes in COVID-19
patients. Intensive Care Med. 2020;46:1873–83.
87. Narinx N, Smismans A, Symons R, Frans J, Demeyere A, Gillis M.
Feasibility of using point-of-care lung ultrasound for early triage of
COVID-19 patients in the emergency room. Emerg Radiol. Springer Science
and Business Media LLC; 2020;
88. S. B, A. L, M. D, E. G, C. B, E. A, et al. The association of lung
ultrasound images with COVID-19 infection in an emergency room cohort.
Anaesthesia. S. Bar, Anaesthesiology and Critical Care Department,
Amiens University Hospital, Amiens, France. E-mail:
stephane.bar.sb@gmail.com: Blackwell Publishing Ltd; 2020;
89. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of
Chest CT for COVID-19: Comparison to RT-PCR. Radiology.
2020;296:E115–7.
90. Zieleskiewicz L, Markarian T, Lopez A, Taguet C, Mohammedi N,
Boucekine M, et al. Comparative study of lung ultrasound and chest
computed tomography scan in the assessment of severity of confirmed
COVID-19 pneumonia. Intensive Care Med. Springer; 2020;46:1707–13.
91. S. O, M. F, E. E, L. D, C. L, M.P. D, et al. Lung ultrasonography in
patients with COVID-19: comparison with CT. Clin Radiol. S. Ottaviani,
Service de Rhumatologie, Hopital Bichat, AP-HP, 46 rue Henri Huchard,
Paris 75018, France. E-mail: sebastien.ottaviani@aphp.fr: W.B. Saunders
Ltd; 2020;
92. Bonadia N, Carnicelli A, Piano A, Buonsenso D, Gilardi E, Kadhim C,
et al. Lung Ultrasound Findings Are Associated with Mortality and Need
for Intensive Care Admission in COVID-19 Patients Evaluated in the
Emergency Department. Ultrasound Med Biol. 2020;46:2927–37.
93. Zhao L, Yu K, Zhao Q, Tian R, Xie H, Xie L, et al. Lung Ultrasound
Score in Evaluating the Severity of Coronavirus Disease 2019 (COVID-19)
Pneumonia. Ultrasound Med Biol. 2020;46:2938–44.
94. Rojatti M, Regli IB, Zanforlin A, Ferretti E, Falk M, Strapazzon G,
et al. Lung Ultrasound and Respiratory Pathophysiology in Mechanically
Ventilated COVID-19 Patients-an Observational Trial. SN Compr Clin Med.
2020;1–8.
95. Andersen CA, Holden S, Vela J, Rathleff MS, Jensen MB. Point-of-Care
Ultrasound in General Practice: A Systematic Review. Ann Fam Med.
2019;17:61–9.
96. Sorensen B, Hunskaar S. Point-of-care ultrasound in primary care: a
systematic review of generalist performed point-of-care ultrasound in
unselected populations. ultrasound J. 2019;11:31.
97. Dargent A, Chatelain E, Kreitmann L, Quenot J-P, Cour M, Argaud L.
Lung ultrasound score to monitor COVID-19 pneumonia progression in
patients with ARDS. PLoS One. 2020;15:e0236312.
98. Moro F, Buonsenso D, Moruzzi MC, Inchingolo R, Smargiassi A, Demi L,
et al. How to perform lung ultrasound in pregnant women with suspected
COVID-19. Ultrasound Obstet Gynecol. John Wiley and Sons Ltd;
2020;55:593–8.
99. Buonsenso D, Raffaelli F, Tamburrini E, Biasucci DG, Salvi S,
Smargiassi A, et al. Clinical role of lung ultrasound for diagnosis and
monitoring of COVID-19 pneumonia in pregnant women. Ultrasound Obstet
Gynecol. John Wiley and Sons Ltd; 2020;56:106–9.
100. Kalafat E, Yassa M, Koc A, Tug N. Utility of lung ultrasound
assessment for probable SARS-CoV-2 infection during pregnancy and
universal screening of asymptomatic individuals. Ultrasound Obstet.
Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol. England; 2020. p.
624–6.
101. Yassa M, Birol P, Mutlu AM, Tekin AB, Sandal K, Tug N. Lung
Ultrasound Can Influence the Clinical Treatment of Pregnant Women With
COVID-19. J Ultrasound Med. John Wiley and Sons Ltd.; 2020;
102. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J,
et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients
Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA
Cardiol. 2020;5:1265–73.
103. Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP,
et al. Cardiovascular Magnetic Resonance Findings in Competitive
Athletes Recovering From COVID-19 Infection. JAMA Cardiol.
2021;6:116–8.
104. Esposito A, Palmisano A, Natale L, Ligabue G, Peretto G, Lovato L,
et al. Cardiac Magnetic Resonance Characterization of Myocarditis-Like
Acute Cardiac Syndrome in COVID-19. JACC Cardiovasc Imaging. A.
Esposito, Experimental Imaging Center, Radiology Unit, IRCCS San
Raffaele Hospital and Scientific Institute, Vita-Salute San Raffaele
University, Via Olgettina 58-60, Milan 20132, Italy. E-mail:
esposito.antonio@hsr.it: Elsevier Inc. (E-mail: usjcs@elsevier.com);
2020;
105. Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac
Involvement in Patients Recovered From COVID-2019 Identified Using
Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020;
106. Clark DE, Parikh A, Dendy JM, Diamond AB, George-Durrett K, Fish
FA, et al. COVID-19 Myocardial Pathology Evaluated Through scrEening
Cardiac Magnetic Resonance (COMPETE CMR). medRxiv Prepr Serv Heal Sci.
2020;